Cargando…
A rare case of immune thrombocytopenia secondary to breast cancer
Immune Thrombocytopenic Purpura (ITP) is in rare cases secondary to solid tumors, particularly breast cancer. In these cases, the clinical course of the ITP may follow the clinical course of the primary tumor, and remission of the ITP may be induced by treatment of the primary tumor.
Autores principales: | Hügli, Sophie, Hügli, Anne, Simonetta, Federico, Chalandon, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333068/ https://www.ncbi.nlm.nih.gov/pubmed/30656035 http://dx.doi.org/10.1002/ccr3.1939 |
Ejemplares similares
-
Tozinameran: Secondary immune thrombocytopenia: case report
Publicado: (2022) -
Azithromycin-Induced Thrombocytopenia: A Rare Etiology of Drug-Induced Immune Thrombocytopenia
por: Butt, Muhammad Umer, et al.
Publicado: (2019) -
A rare case of vaccine-induced immune thrombosis and thrombocytopenia and approach to management
por: Kotal, Raghavendra, et al.
Publicado: (2021) -
Drug‐induced immune‐mediated thrombocytopenia secondary to durvalumab use
por: Dougherty, Sean C., et al.
Publicado: (2021) -
Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination
por: Fueyo-Rodriguez, Omar, et al.
Publicado: (2021)